Published in Brain Pathol on July 01, 2000
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med (2008) 4.24
CNS immune privilege: hiding in plain sight. Immunol Rev (2006) 3.13
Axonal injury heralds virus-induced demyelination. Am J Pathol (2003) 1.38
The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res (2006) 1.24
Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol (2006) 1.16
Immunity and inflammation in neurodegenerative diseases. Am J Neurodegener Dis (2013) 1.08
Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol (2001) 1.07
Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis. J Neuroimmune Pharmacol (2009) 1.01
Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review. BMC Vet Res (2013) 0.97
Modeling multiple sclerosis in laboratory animals. Semin Immunopathol (2009) 0.94
Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am J Pathol (2005) 0.94
Role of CD5+ B-1 cells in EAE pathogenesis. Autoimmunity (2008) 0.92
Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine (2010) 0.91
TGF-beta1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus. J Neuroimmunol (2007) 0.91
Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration. Pathophysiology (2011) 0.91
The importance of NAD in multiple sclerosis. Curr Pharm Des (2009) 0.89
Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design. Comp Med (2009) 0.87
Experimental Autoimmune Encephalomyelitis in Mice. Methods Mol Biol (2016) 0.86
Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis. J Immunol (2014) 0.86
Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease? Pathophysiology (2012) 0.85
Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice. Int J Mol Sci (2014) 0.84
Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity. J Neuroimmunol (2007) 0.84
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models. Inflammopharmacology (2014) 0.84
Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis. Brain Behav Immun (2014) 0.83
Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis. J Neuroimmunol (2007) 0.79
Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis. J Neurovirol (2008) 0.78
Cross-reactive myelin antibody induces renal pathology. Autoimmunity (2008) 0.77
Role of B:T cell ratio in suppression of clinical signs: a model for silent MS. Exp Mol Pathol (2008) 0.75
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis. J Neurovirol (2012) 0.75
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science (1985) 3.68
Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A (1983) 2.12
Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature (1979) 1.75
Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol (1996) 1.67
A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J Virol (1989) 1.59
Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest (1986) 1.53
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin. J Immunol (1983) 1.46
Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J Immunol (1980) 1.45
Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology (1997) 1.41
Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells. J Virol (1988) 1.41
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med (1989) 1.39
Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes. J Exp Med (1986) 1.24
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol (2001) 1.21
The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am J Pathol (1990) 1.20
Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J Infect Dis (1989) 1.19
Characterization of in vitro transcription and transcriptional products of measles virus. J Virol (1987) 1.14
Failure to cleave measles virus fusion protein in lymphoid cells. J Exp Med (1981) 1.13
Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol (1998) 1.11
Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J Neuropathol Exp Neurol (1997) 1.09
Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med (1990) 1.08
Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell. Virology (1983) 1.07
Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus. Am J Pathol (1993) 1.07
Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol (1994) 1.05
Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol (1999) 1.04
Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant. J Virol (1991) 1.03
Viruses can silently prime for and trigger central nervous system autoimmune disease. J Neurovirol (2001) 1.03
Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen. Prog Med Virol (1980) 1.02
Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus. Microb Pathog (1995) 1.00
Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol (1999) 0.98
Immune reactive measles virus polypeptides on the cell's surface: turnover and relationship of the glycoproteins to each other and to HLA determinants. J Immunol (1981) 0.98
Antigenic modulation induced by monoclonal antibodies: antibodies to measles virus hemagglutinin alters expression of other viral polypeptides in infected cells. J Immunol (1984) 0.97
Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J Neuroimmunol (2000) 0.96
Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. J Virol (1991) 0.96
Pathogenesis of Theiler's murine encephalomyelitis virus. Adv Virus Res (1991) 0.95
Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1993) 0.94
Molecular mimicry: a mechanism for autoimmune injury. FASEB J (1992) 0.93
Viruses as triggers of autoimmunity: facts and fantasies. Curr Opin Microbiol (1999) 0.91
Measles virus infection of human T cells modulates cytokine generation and IL-2 receptor alpha chain expression. Virology (1997) 0.91
Purification of measles virus glycoproteins and their integration into artificial lipid membranes. J Gen Virol (1981) 0.91
Serologic relatedness between Thy-1.2 and actin revealed by monoclonal antibody. J Immunol (1983) 0.89
DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J Virol (1999) 0.88
Cellular transfer of experimental allergic encephalomyelitis employing suckling and adult Lewis rats. J Clin Lab Immunol (1981) 0.87
Experimental allergic encephalomyelitis in suckling Lewis rats: comparison with the disease in adult animals. Lab Invest (1977) 0.87
Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression. Virology (1998) 0.86
Induction of experimental allergic encephalomyelitis in suckling Lewis rats: role of age and type of sensitizing neuroantigen. J Immunol (1977) 0.86
Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection. J Neuroimmunol (1998) 0.85
Lipopeptide particles as the immunologically active component of CTL inducing vaccines. Vaccine (1999) 0.85
Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis. J Neuroimmunol (1999) 0.83
Antigenic mimicry between measles virus and human T lymphocytes. J Infect Dis (1987) 0.83
Effects of regional spinal X-irradiation on demyelinating disease caused by Theiler's virus, mouse hepatitis virus or experimental allergic encephalomyelitis. J Neuroimmunol (1987) 0.83
Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10. J Neuroimmunol (1998) 0.83
Antisense-mediated resistance to measles virus infection in HeLa cells. J Infect Dis (1997) 0.82
Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats. J Exp Med (1978) 0.82
Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J Neuroimmunol (1996) 0.82
B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease. J Virol (1995) 0.82
Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1997) 0.82
Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing-remitting experimental allergic encephalomyelitis. J Neuroimmunol (1999) 0.81
MBP-SF, a prominent serum factor in suckling Lewis rats that additively inhibits the primary binding of myelin basic protein (MBP) to syngeneic anti-MBP antibodies. Immunochemistry (1978) 0.80
Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus. J Neurovirol (2001) 0.80
Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem. Trans Am Clin Climatol Assoc (1978) 0.79
Antigenic modulation: a mechanism of viral persistence. Prog Brain Res (1983) 0.79
Imaging study of the long extracranial extension of the inferior petrosal sinus with MSCT. Clin Anat (2010) 0.78
Rapid accumulation of measles virus leader RNA in the nucleus of infected HeLa cells and human lymphoid cells. J Virol (1991) 0.78
Lack of correlation of Theiler's virus binding to cells with infection. J Neurovirol (1997) 0.77
Theiler's murine encephalomyelitis virus contrasts with encephalomyocarditis and foot-and-mouth disease viruses in its functional utilization of the StopGo non-standard translation mechanism. J Gen Virol (2012) 0.77
Immune responses against myelin basic protein and/or galactocerebroside cross-react with viruses: implications for demyelinating disease. Curr Top Microbiol Immunol (1989) 0.77
Characterization of a murine central nervous system-derived cell line: infectability and presentation of viral antigen. J Neuroimmunol (1994) 0.75
Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1993) 0.75
Immunity to viruses. Curr Opin Immunol (1990) 0.75
Immunity to viruses. Curr Opin Immunol (1989) 0.75
Lack of suppressive effect of alpha-foetoprotein on development of experimental allergic encephalomyelitis in rats. Nature (1977) 0.75
DNA immunization and central nervous system viral infection. Adv Virus Res (2001) 0.75